-
1781
The Impact of the COVID-19 Pandemic on Health and Health Care Experience in Those With Polycystic Ovary Syndrome
Published 2025-02-01“…PCOS is associated with an increased risk of infertility, pregnancy complications, obesity, type 2 diabetes, cardiovascular diseases, and mental health disorders such as anxiety, depression, and negative self-image. …”
Get full text
Article -
1782
Clonal hematopoiesis of indeterminate potential is a risk factor of gastric cancer: A Prospective Cohort in UK Biobank study
Published 2025-02-01“…Setting: Data on age, sex, race, alcohol consumption, smoking status and type 2 diabetes were collected at baseline interview. …”
Get full text
Article -
1783
Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
Published 2018-01-01“…Chronic hepatitis C is a systemic disease and type 2 diabetes mellitus (T2DM) belongs to more common extrahepatic. …”
Get full text
Article -
1784
Is maternal diabetes during pregnancy associated with neurodevelopmental, cognitive and behavioural outcomes in children? Insights from individual participant data meta-analysis in...
Published 2025-01-01“…A pre-existing maternal history of type 1 and type 2 diabetes mellitus was associated with ADHD symptoms at 4–6 years (model 1, β 8.82 (95% CI 2.21, 15.45, P = 0.009) and β 7.90 (95% CI 0.82, 14.98, P = 0.02), respectively). …”
Get full text
Article -
1785
A Comparative Study of Health Efficacy Indicators in Subjects with T2DM Applying Power Cycling to 12 Weeks of Low-Volume High-Intensity Interval Training and Moderate-Intensity Con...
Published 2022-01-01“…This study is aimed at comparing the effects of different exercise intensities, namely, high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), on body composition, heart and lung fitness, and blood glucose, and blood pressure indices in patients with type 2 diabetes mellitus (T2DM), using power cycling. …”
Get full text
Article -
1786
The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Published 2025-03-01“…The meta-analysis revealed a beneficial effect of SGLT-2 inhibitors on liver functions and body weight, BMI, TG, HDL-C, and glucose homeostasis in patients with NAFLD, indicating that SGLT-2 inhibitors might be a clinical therapeutic strategy for these patients, especially individuals with concurrent type 2 diabetes mellitus (T2DM).…”
Get full text
Article -
1787
Endocrine disruptors and cancers. [Perturbateurs endocriniens et cancers]
Published 2024-12-01“…Some are toxic for the reproductive function in men via a drop in sperm concentration, others are neurotoxic (Parkinson disease, behavioral disorders) but also those involved in the increasing incidence of chronic diseases, such as type 2 diabetes, obesity and certain hormone-sensitive cancers. …”
Get full text
Article -
1788
Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver disease
Published 2025-02-01“…Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterised by lipid accumulation in the liver and is often associated with obesity and type 2 diabetes. The gut microbiome recently emerged as a significant player in liver metabolism and health. …”
Get full text
Article -
1789
Cohort profile: the BangladEsh Longitudinal Investigation of Emerging Vascular and nonvascular Events (BELIEVE) cohort study
Published 2025-01-01“…Focusing only on the 65 822 adult participants aged 20–79 years at baseline, 15 411 (23%) reported being diagnosed with hypertension; 10 578 (16%) with type 2 diabetes and 7624 (12%) with hypercholesterolaemia. …”
Get full text
Article -
1790
Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic Rats
Published 2016-01-01“…Our previous studies testified the beneficial effect of central galanin on insulin sensitivity of type 2 diabetic rats. The aim of the study was further to investigate whether central M617, a galanin receptor 1 agonist, can benefit insulin sensitivity. …”
Get full text
Article -
1791
Characterization of Ischemic Cerebrovascular Disease in Diabetic Patients at the General Calixto García Clinical Surgical University Hospital
Published 2023-07-01“…In the Americas they constitute the third cause of death and their incidence is increased in type 2 diabetic patients. <br /><strong>Objective:</strong> to characterize type 2 diabetic patients with acute ischemic cerebrovascular disease. …”
Get full text
Article -
1792
Reduced TCA Flux in Diabetic Myotubes: Determined by Single Defects?
Published 2012-01-01“…ATP production was measured by luminescence with or without concomitant ATP utilisation by hexokinase in mitochondria isolated from myotubes established from eight lean and eight type 2 diabetic subjects. The ATP production of investigated substrate combinations was significantly reduced in mitochondria isolated from type 2 diabetic subjects compared to lean. …”
Get full text
Article -
1793
The Need for Improved Management of Painful Diabetic Neuropathy in Primary Care
Published 2016-01-01“…The provision of care for patients with type II diabetes in primary care must involve assessing patients for peripheral neuropathy of the feet. …”
Get full text
Article -
1794
Plasma Gelsolin Levels Decrease in Diabetic State and Increase upon Treatment with F-Actin Depolymerizing Versions of Gelsolin
Published 2014-01-01“…The study aims to map plasma gelsolin (pGSN) levels in diabetic humans and mice models of type II diabetes and to evaluate the efficacy of gelsolin therapy in improvement of diabetes in mice. …”
Get full text
Article -
1795
Therapeutic molecules for multiple human diseases identified from pigeon pea (Cajanus cajan L. Millsp.) through GCâMS and molecular docking
Published 2017-12-01“…Keywords: Breast cancer, Drug discovery, Herbal medicine, In silico, Malaria, Measles, Phyto-compounds, Rheumatoid arthritis, Sickle cell disease, Type II diabetes…”
Get full text
Article -
1796
Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients
Published 2019-01-01“…This study investigated the effect of Trigonella foenum-graecum seed powder solution on the lipid profile of newly diagnosed type II diabetic patients. Methods. A total of N=114 newly diagnosed type II diabetic patients without any significant diabetes complication were selected. …”
Get full text
Article -
1797
A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling
Published 2023-01-01“…Then, LMT-28 was administered by gavage at 0.23 mg/kg once every 5 days for 2 weeks to type 2 diabetic rats with peri-implantitis induced by LPS injection and silk ligature. …”
Get full text
Article -
1798
Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives
Published 2016-01-01“…Because of the probable link between hIAPP and the development of type II diabetes, there has been strong interest in developing reagents to study the aggregation of hIAPP and possible therapeutics to block its toxic effects. …”
Get full text
Article -
1799
Correlation of serum C - reactive protein with clinical parameters in diabetic patients having chronic periodontitis before and after treatment
Published 2020-06-01“…The present study was performed to determine whether presence of periodontitis and non-surgical periodontal therapy could influence the serum levels of CRP in type II diabetes mellitus disease patients. Materials and methods: A total of 60 subjects were selected for study. …”
Get full text
Article -
1800
C-Peptide: A New Mediator of Atherosclerosis in Diabetes
Published 2012-01-01“…In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients.…”
Get full text
Article